Related Experiment Videos
Differential diagnosis of intracavitary tumors obstructing the right ventricular outflow tract
A S Gopal1, J A Stathopoulos, N Arora
1New York Hospital, Medical Center of Queens, Flushing, NY 11355, USA.
Insights
Right ventricular outflow tract obstruction can stem from various tumors like myxoma or sarcoma. Tumors in this location are statistically more likely to be malignant, emphasizing the need for accurate diagnosis.
Area of Science:
- Cardiology
- Oncology
- Diagnostic Imaging
Background:
- Right ventricular outflow tract obstruction (RVOTO) is a critical condition.
- Cardiac tumors, though rare, can cause significant hemodynamic compromise.
- Distinguishing between tumor types presenting with similar echocardiographic findings is clinically important.
Observation:
- Presents three distinct cases of RVOTO caused by myxoma, sarcoma, and a presumed metastatic tumor.
- Utilized transthoracic echocardiography (TTE) and transesophageal echocardiography (TEE) for diagnosis.
- Highlighted subtle differences in clinical and echocardiographic presentations among the tumor types.
Findings:
- Intracavitary RVOT tumors are statistically 70-140 times more likely to be malignant than benign.
- Primary cardiac tumors in the RVOT are approximately twice as likely to be sarcoma than myxoma.
- Echocardiography is crucial for diagnosing and characterizing RVOT masses.
Implications:
- Emphasizes the high probability of malignancy for RVOT tumors.
- Underscores the importance of advanced echocardiography in differentiating cardiac masses.
- Informs clinical suspicion and diagnostic workup for patients with RVOTO and suspected cardiac tumors.
Abstract:
Three cases of right ventricular outflow tract obstruction caused by 3 distinct tumors-myxoma, sarcoma, and presumed metastatic tumor-diagnosed by transthoracic and transesophageal echocardiography are presented. The differences among these 3 types of tumors with similar clinical and echocardiographic findings are highlighted, and a review of the pertinent literature is discussed. By applying the approximate frequencies of cardiac tumors categorized by type and site, statistically, an intracavitary right ventricular outflow tract tumor is 70 to 140 times more likely to be malignant than benign; furthermore, if it is a primary cardiac tumor, it is approximately 2 times more likely to be a sarcoma than a myxoma.